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Latent Epstein–Barr virus genome is maintained in cells by the viral oriP-binding factor EBNA1 and cellular replication
factors. EBNA1 binds to the dyad symmetry (DS) element in oriP and initiates DNA replication once in a single S phase, but
the mechanism by which this DS-dependent replication is initiated is unknown. Replication licensing of cellular chromatins
occurs during early G1 phase. Because licensing is essential for the next round of replication in S phase, it facilitates
once-in-a-cell-cycle replication of the cellular genome. Using the transient replication assay with HeLa/EB1 cell, we
demonstrate that the oriP plasmid required a cell cycle window including early G1 phase for replication in the next S phase.
The plasmid containing only the DS element had a similar requirement of early G1 phase for replication. Analysis using
sucrose density gradient centrifugation revealed that the oriP minichromosome existed in two distinct states: one formed at
late G1 and the other formed at G2/M. These results suggest that the DS-dependent DNA replication from oriP requires the
replication licensing, implying a possible involvement of the cellular licensing factor MCM in the DNA replication from oriP.
© 1999 Academic Press
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sINTRODUCTION
Epstein–Barr virus (EBV) is a human herpesvirus that
s related to several proliferative disorders: Burkitt’s lym-
homa, T cell lymphoma, gastric carcinoma, infectious
ononucleosis, and opportunistic lymphoma of immuno-
uppressed patients. The DNA genome of EBV is repli-
ated from two types of origins located in distinct re-
ions: oriLyt and oriP (reviewed in Yates, 1996). oriLyt is
sed during lytic phase of the viral life cycle and initiates
rolling cycle-type replication with several virus-en-
oded replication factors for virus production. oriP func-
ions during latent infection and initiates bidirectional
eplication to maintain the episomal EBV genome in host
ells (Yates et al., 1984). In contrast to oriLyt, oriP re-
uires only the origin-binding protein EBNA1 as a viral
rotein (Lupton and Levine, 1985; Yates et al., 1985) and
nitiates only one round of replication in a single S phase
Adams, 1987; Yates and Guan, 1991).
oriP is 2.2 kb long and has two clusters of EBNA1
inding sites: the family of repeats (FR) and the dyad
ymmetry (DS) elements (Lupton and Levine, 1985; Reis-
an et al., 1985; Rawlins et al., 1985). The FR element
ontains 20 EBNA1 binding sites and works to attach the
BV chromosome to nuclear matrix and maintain the
enome in nuclei (Krysan et al., 1989; Jankelevich et al.,
992; Middleton and Sugden, 1994; Shire et al., 1999).
1 To whom reprint requests should be addressed. Fax: 81-3-5803-
f241. E-mail: hirai.creg@mri.tmd.ac.jp.
042-6822/99 $30.00
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42he FR element also acts as a replication enhancer, as
ell as a transcriptional enhancer (Wysokenski and
ates, 1989). The DS element consists of four EBNA1
inding sites. DNA replication is initiated from the sites
t or very close to the DS element, which is the minimal
lement required for the replication (Gahn and Schild-
raut, 1989; Wysokenski and Yates, 1989; Harrison et al.,
994; Niller et al., 1995; Shirakata and Hirai, 1998). Thus
he DS element functions as a replication origin.
The DS element is not necessarily active as a replica-
ion origin in EBV-infected cells, and occurrence of the
S-independent replication is also reported. In a Burkitt’s
ell line Raji, DNA replication of the EBV genome ini-
iates mainly at multiple sites in a region distant from oriP
Little and Schildkraut, 1995). It was also demonstrated
hat some plasmids containing oriP can replicate without
he DS element in the EBNA1-expressing 143B and 293
ells (Kirchmaier and Sugden, 1998, Aiyar et al., 1998). In
hese cells, EBNA1 does not assemble DNA synthetic
achinery at oriP but works to prevent loss of the oriP-
ontaining plasmids (Aiyar et al., 1998). Some elements
n the EBV genome and the oriP-containing plasmid work
s a replication origin when the DS-independent repli-
ation occurs.
In the DS-dependent replication, the EBNA1 binding to
he DS region is essential for the DNA replication from
riP, but the function of EBNA1 is poorly understood.
oth FR and DS elements contain the EBNA1 binding
ites, but the spacing between the binding sites is dif-erent. This causes functional segregation of the two
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43LICENSING OF EBV oriPBNA1-binding elements. EBNA1 forms dimers and
inds to a recognition sequence (Bochkarev et al., 1995,
996), and its binding to the FR and DS elements is
onstitutive during the cell cycle (Hsieh et al., 1993).
revious studies showed that EBNA1 induces distortion
f the DNA structure at the binding site (Frappier and
’Donnell, 1992; Hsieh et al., 1993) and that EBNA1 forms
DNA loop within oriP via EBNA1–EBNA1 interactions
Frappier and O’Donnell, 1991b; Su et al., 1991; Makey et
l., 1995). However, EBNA1 has none of the replication-
elated enzymatic activities of DNA helicase, polymer-
se, or ATPase (Frappier and O’Donnell, 1991a; Middle-
on and Sugden, 1992) and the mechanism by which
eplication from oriP is initiated is not known.
The latent EBV genome replicates once in a single S
hase like the cellular genome (Adams, 1987; Yates and
uan, 1991). It is unknown whether the cellular replica-
ion licensing or other mechanisms specific for the EBV
eplication regulate the once-in-a-cell-cycle replication of
riP. Replication licensing of cellular chromatins occurs
uring early G1 phase (Blow and Laskey, 1988). The
icensing factor MCM (Chong et al., 1995; Kubota et al.,
995; Madine et al., 1995) is loaded at replication origins
o form the prereplicative complex with ORC1–6 (Bell and
tillman, 1992) and then the origins become competent
or the next round of DNA replication (reviewed in
ewlon, 1997). Because replication licensing of cellular
hromatins is essential for DNA replication in the next S
hase, if oriP is regulated by a similar licensing mecha-
ism, oriP may also require early G1 phase for the next
ound of replication in S phase.
We have previously shown that the plasmid containing
riP (the oriP plasmid) replicates efficiently in the HeLa
ells expressing EBNA1 (HeLa/EB1) (Shirakata and Hirai,
998). The DS element is the minimal element required
or the replication in HeLa/EB1, which is 30% as efficient
s that of oriP. The plasmid containing only the FR
lement is retained in cells as well as the oriP plasmid,
ut its replication in HeLa/EB1 is ,1% of the oriP plas-
id. Thus in HeLa/EB1, the DS-independent replication
ccurs very little and the oriP replication depends mostly
n EBNA1 and the DS element in the plasmid.
In this study, we examined whether replication from
riP is regulated by a licensing mechanism. To deter-
ine whether oriP requires early G1 phase for the next
eplication, we transfected the oriP plasmid into HeLa/
B1 and examined replication in the initial S phase by
locking the cell cycle progression at G2/M after trans-
ection. Our results indicated that a cell cycle window
ncluding early G1 phase was required for the next rep-
ication of the oriP plasmid. Centrifugation analysis also
evealed that the oriP minichromosome existed in two
istinct states: one formed at late G1 phase and the
ther formed at G2/M phase. From these results, we
uggest that the DS-dependent replication of EBV ge-
ome requires a replication licensing. cRESULTS
he transfected oriP plasmid did not replicate in the
nitial S phase under G2/M block
To determine whether oriP requires early G1 phase for
ext round of replication, we examined replication of the
riP plasmid in the initial S phase after transfection
nder the condition that the cell cycle progression was
locked at G2/M. The oriP plasmid had the 2.2-kb oriP
egion containing both FR and DS elements. We trans-
ected this dam methylated oriP plasmid together with
he dam methylated and unmethylated control plasmids
nto asynchronous HeLa/EB1 cell, an HeLa cell line sta-
ly expressing EBNA1 (Shirakata and Hirai, 1998). Imme-
iately after transfection, these cells were treated with
ocodazole to arrest the cell cycle at G2/M. The cell
ycle analysis by FACS confirmed that 98% of the no-
odazole-treated cells were in G2/M within 24 h. As a
ontrol, another set of transfected cells were cultured
ithout blocking the cell cycle. Cells were collected at
4, 48, and 72 h after transfection, and the plasmids were
ecovered from the total cell in a dish according to Hirt’s
ethod and suspended in 50 ml. The same volume of
ample (5 ml, 10% of total cells) was used to analyze
eplication by the DpnI–MboI assay (see Materials and
ethods). In this assay, the unreplicated oriP plasmid is
pnI sensitive and MboI resistant. The plasmid repli-
ated only once in cells is DpnI resistant and MboI
esistant, and the plasmid replicated more than twice is
pnI resistant and MboI sensitive. Figure 1A shows the
esult of Southern hybridization analysis of these DpnI–
boI digests. In the sample collected from the control
ells at 24 h, we detected some DpnI-resistant oriP
lasmids (lane 1) and no significant amount of MboI-
ensitive (digested) plasmids (lane 7). This indicated that
ome oriP plasmids replicated once within 24 h after
ransfection. Complete digestion with DpnI and MboI
as confirmed by the absence of the DpnI-resistant
ethylated control or the MboI-resistant unmethylated
ontrol plasmids. By 48 h after transfection, the DpnI-
esistant and MboI-sensitive oriP plasmids had ap-
eared (lanes 2 and 8), and their number had increased
urther by 72 h (lanes 3 and 9). The appearance of these
wice-replicated oriP plasmids at 48 h but not at 24 h was
onsistent with the doubling time of HeLa/EB1 (;24 h).
mounts of total and replicated oriP plasmids were es-
imated from the signal of standard plasmid run in par-
llel in an agarose gel and are shown in Table 1. In
ontrast to these unblocked cells, when the cell cycle
rogression was blocked at G2/M immediately after
ransfection, the DpnI-resistant oriP plasmids were not
etected at 24 h (lanes 4 and 10). The replicated oriP
lasmids had not appeared even at 48 h (lanes 5 and 11).
e observed that some oriP plasmids were replicated in
he nocodazole-blocked cells at 72 h, because the no-
odazole-block became leaky in the prolonged culture.
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44 SHIRAKATA, IMADOME, AND HIRAIignals of the replicated plasmids were quantified and
ormalized to those of the control plasmids. The results
f three experiments were summarized and shown in
ig. 1B. These results suggested that the oriP plasmid
id not replicate in the initial S phase under G2/M block.
In this G2/M arrest experiment, the oriP plasmids were
ransfected into asynchronous cells. To confirm that plas-
ids were introduced into G1 and S cells according to
he calcium phosphate method, we transfected a plas-
id expressing the green fluorescence protein (GFP)
nto HeLa/EB1 cells and analyzed the cell cycle distribu-
ion of the GFP-expressing (GFP1) cells at 2 and 24 h
fter the glycerol shock treatment. About 10% of trans-
FIG. 1. The transfected oriP plasmid did not replicate in the initial S p
he DpnI–MboI assay. The oriP plasmid [oriP, 3 mg], the dam methylate
2), 3 mg] were cotransfected into HeLa/EB1. The transfected cells wer
Nocodazole). Another set of cells was cultured in normal medium (Co
lasmids (5 ml) corresponding to 10% of total cells in a culture dish we
o linearize plasmids. The hybridization probe was a 1-kb DpnI fragme
resistant) and 2-kb sensitive (digested) fragments of the oriP plasmid (o
lasmid [control (1)], and 6-kb resistant and 2.9-kb digested fragments
nrelated to the DpnI–MboI assay (see Materials and Methods). (B) S
boI-digested oriP plasmids in the total cells in a dish were estimated
odel BAS2000 and use of a known amount of the oriP plasmid as stan
ontrol plasmids.ected cells expressed already detectable amounts ofFP at 2 h (Fig. 2A). Although the double fixation with
araformaldehyde and ethanol resulted in lower resolu-
ion of cell cycle analysis, the analysis using the ModFit
T V2.0 program indicated that 41.0% of GFP1 cells were
n G0/G1 and 34.5% were in S phase. This distribution
as very similar to those of unexpressing cells (GFP2):
6.1% in G0/G1 and 30.9% in S. At 24 h after glycerol
hock, GFP1 cells increased to 99.4% of total cells in
his experiment, and the cell cycle distribution of the
FP1 cells was also similar to those collected at 2 h
Fig. 2B). From these results, we concluded that the oriP
lasmids were effectively introduced into G1 and S cells
ccording to the calcium phosphate method.
nder G2/M block. (A) Replication of the oriP plasmid was analyzed by
rol plasmid [control (1), 3 mg], and the unmethylated plasmid [control
red in the presence of nocodazole for 24, 48, or 72 h after transfection
ocodazole blocks the cell cycle progression at G2/M. The recovered
sted with DpnI or MboI. These samples were also digested with XbaI
luescript II KS2 plasmid, which detected 5.2-kb DpnI–MboI-resistant
b resistant and 1-kb digested fragments of the dam methylated control
unmethylated plasmid [control (2)]. The band indicated by a star was
y of three experiments. Amounts of DpnI-resistant oriP plasmids and
lyzing the Southern hybridization membranes with Fuji image analyzer
ignals of model BAS200 analysis were also normalized by the internalhase u
d cont
e cultu
ntrol). N
re dige
nt of pB
riP), 3-k
of the
ummar
by ana
dard. STo confirm the absence of replication of the oriP plas-
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45LICENSING OF EBV oriPid in the initial S phase under G2/M block, we per-
ormed a 5-Bromo-29-deoxyribouridine (BRdU)-labeling
xperiment. After transfection of the oriP plasmid, the
ells were cultured in the medium containing BRdU to
abel newly synthesized DNA and were simultaneously
locked at G2/M with nocodazole. The control cells were
ultured in the BRdU medium without nocodazole. After
4 h, the plasmid DNA was extracted from the cells and
nalyzed by density equilibrium centrifugation in CsCl. In
he control cells, labeled heavy-light plasmid DNA were
ynthesized, but this newly synthesized plasmid was not
etected in the nocodazole-blocked cells (Fig. 3A). Total
NA was also prepared from the same cells and ana-
yzed. The genomic DNA was similarly labeled in control
nd nocodazole-blocked cells (Fig. 3B). These results
onfirmed that the transfected oriP plasmid did not rep-
icate in the initial S phase under G2/M block.
It is known that the replication licensing does not
egulate SV40 ori, and the origin initiates multiple rounds
f replication in a single S phase. As a control experi-
ent of the oriP plasmid, we examined replication of an
V40 ori plasmid in a similar transient replication assay.
he plasmid contained the replication origin of SV40 and
he gene for expressing large T antigen. We confirmed
hat SV40 ori plasmid replicated in the initial S phase
ven under G2/M block (data not shown).
he transfected oriP plasmid replicated in the
ubsequent S phase after release from G2/M block
We next examined whether the oriP plasmid replicates
n the subsequent S phase after release from G2/M
lock. We cultured the transfected cells under nocoda-
ole block for 24 h and then released the block by
hanging the culture medium to normal medium (Fig.
TABLE 1
Replication of the oriP Plasmid in HeLa/EB1 Cells
oriP plasmid
Control Nocodazole
24 ha 48 h 72 h 24 h 48 h 72 h
otal (ng) 38.1 38.7 51.7 47.5 30.9 22.2
eplicated plasmid
DpnI resistant ng 4.4 15.0 36.3 0.32 0.68 1.96
% total 11.4 38.8 70.2 0.6 2.1 8.8
boI sensitive ng 0.0 6.6 33.2 0.36 0.64 1.64
% total 0.0 17 64.1 0.7 2.0 7.3
Note. Plasmid amount present in all of the transfected cells in a culture
ish was estimated from the results of DpnI-MboI assay described in Fig.
A.
a Time after transfection.A). At the time of release (0 h), the replicated oriP elasmid was not detected (Fig. 4B, lanes 1 and 5). DpnI-
esistant oriP plasmids appeared at 24 h after release
lane 2), but MboI-sensitive plasmids were not yet syn-
hesized (lane 6). This indicated that the oriP plasmid
eplicated once in 24 h after release from G2/M block.
ecause the doubling time of these cells was ;24 h, this
eplication occurred in the subsequent S phase after the
locked G2/M. The MboI-sensitive plasmids that repli-
ated twice appeared at 48 h after release, when many
ells had undergone two cell cycles after release from
2/M block (lane 7). Thus the oriP plasmid replicated in
he S phase only after the transfected plasmids pro-
eeded through the initial G2/M phase. The percentage
f replicated oriP plasmid compared with total oriP plas-
id in cells was 8% at 24 h, 24% at 48 h, and 28% at 72 h.
he lower value suggested that some cells were dam-
ged by nocodazole treatment.
24-h delay of G2/M block allowed the oriP plasmid
ne round of replication
We first cultured the transfected cells under normal
onditions for 24 h, and then the cell cycle was blocked
t G2/M (Fig. 5A). With this delayed G2/M block protocol,
ost transfected cells experienced the initial G2/M
hase within 24 h (one cell cycle) after transfection and
hen stopped at the second G2/M phase during the next
4 h. If the oriP plasmid requires the cell cycle window,
ncluding the early G1 phase, for the next DNA replica-
ion, the plasmid should replicate in these cells only
nce, not twice. In control cells, the DpnI-resistant oriP
lasmid appeared within 24 h after transfection and had
ncreased in number at 48 h (Fig. 5B, lanes 1 and 2).
boI-sensitive plasmids, which replicated twice, were
ot detected at 24 h but appeared by 48 h (lanes 5 and
). In the cells treated with the delayed G2/M block,
pnI-resistant oriP plasmids were synthesized with sim-
lar kinetics (lanes 3 and 4), but no MboI-sensitive oriP
lasmids were detected at 48 h (lane 8). The results of
hree experiments are summarized in Fig. 5C; these
esults indicated that the oriP plasmid replicated only
nce in the delayed G2/M block cells and confirmed that
he oriP plasmid required the cell cycle window, includ-
ng thr early G1 phase, for the next round of replication in
phase.
he DS element was responsible for the cell
ycle-regulated replication
We next asked whether the DS element, the minimal
lement required for replication, is responsible for the
ell cycle regulation of the oriP plasmid replication or
hether other cis-acting elements in the oriP region play
role. We examined the DS plasmid in a similar G2/M
lock experiment. The DS plasmid contained only the DS
lement in the same plasmid vector used for the oriP
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46 SHIRAKATA, IMADOME, AND HIRAIlasmid. Although the replication of the DS plasmid was
ess efficient than that of the oriP plasmid (Shirakata and
irai, 1998), DpnI-resistant DS plasmids were detected
t 24 h after transfection (Fig. 6, lane 1). In contrast, the
pnI-resistant DS plasmid was not detected in the cells
rrested at G2/M (lanes 4–6). Thus like the oriP plasmid,
he DS plasmid did not replicate in the initial S phase
nder G2/M block. This result indicated that the DS
egion was responsible for the cell cycle-dependent reg-
FIG. 2. Cell cycle distribution of the plasmid-transfected cells. The
ccording to the calcium phosphate method. Cells were collected at 2 h
ontent of ;170,000 cells were analyzed by FACS Calibur. The dotted li
he G2/M peak (2C) were indicated. Double fixation method with parafor
n lower resolution of 1C and 2C peaks. Compared with the standard e
igher in G2/M. ModFit LT V2.0 program was used to analyze cell cyclation of the replication. retention of the replicated oriP plasmid
n HeLa/EB1 cell
To determine the efficiency in nuclear retention of the
eplicated oriP plasmid in HeLa/EB1, we compared the
opy number of the replicated oriP plasmid in the same
umber of cells (1 3 105) at 4, 8, 12, 16, and 20 days after
ransfection. The plasmid copy number was estimated
rom the signal of Southern hybridization and normalized
o that at 4 days after transfection. As shown in Fig. 7, the
expressing plasmid pEGFP-C2 was transfected into HeLa/EB1 cells
24 h (B) after glycerol treatment and fixed. Expression of GFP and DNA
re mock-transfected control cells. Position of the G0/G1 peak (1C) and
yde and ethanol was used to fix GFP in cells, which, however, resulted
fixation, the percentage of cell cycle phases was lower in G0/G1 and
ibution.GFP-
(A) or
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47LICENSING OF EBV oriPnd became 50% at 20 days after transfection, which
orresponded to 50% decrease for 16 days. Based on
his result, the rate of the retention of the oriP plasmid
as estimated as 0.96 per generation, indicating that
4% of the plasmids were lost from cells during a single
eneration. We also analyzed retention of the DS plas-
id. Because the DS plasmid lacked the FR element that
as important for the nuclear retention, the rate of the DS
lasmid was as low as 0.72 per generation, correspond-
ng to 28% loss per generation. The plasmid loss in our
ransient replication assay, 4% for the oriP plasmid and
8% for the DS plasmid, resulted in a lower estimation of
he amount of replicated but did not account for the
bsence of replicated plasmids in the G2/M block exper-
ments (Figs. 1 and 3) and for the absence of twice-
eplicated plasmids in the experiment with 24-h delay of
2/M block (Fig. 5).
entrifugation analysis of the oriP minichromosome
Requirement of the cell cycle window, including early
1 phase, for the replication from oriP suggested that
ome modifications or structural changes might occur in
he circular minichromosome of the oriP plasmid (the
riP minichromosome) between G2/M and late G1. We
nalyzed the minichromosomes by sucrose density gra-
ient centrifugation. We cotransfected the oriP plasmid
FIG. 3. BRdU labeling of the transfected oriP plasmid. HeLa/EB1 cell
nd nocodazole for 24 h. Control cells were cultured without nocodazo
enomic DNA was prepared from same cells. DNA was analyzed by de
y Southern hybridization using the oriP or Alu repetitive sequence as
he density of each fraction was measured. Fractions of heavy-heavy (H
A) The oriP plasmid. (B) Genomic DNA. PSL is the unit of radioisotopnd the SV40 ori plasmid into HeLa/EB1 cells. The SV40 tlasmid was chosen for the internal control because
ellular replication licensing did not regulate the SV40
rigin. The transfected cells were cultured for 2 days and
hen treated with nocodazole or mimosine for 24 h to
rrest cells at G2/M or late G1 phase. FACS analysis
onfirmed that 98% of the nocodazole treated cells were
n G2/M and 90% of mimosine-arrested cells were in
0/G1. We extracted minichromosomes from nocoda-
ole- and mimosine-treated cells with 1% Triton X-100.
he yield of oriP minichromosome was 10–30%. Forma-
ion of the chromosomal structure of these plasmids was
onfirmed by microccocal nuclease analysis (results not
hown). These extracts were then analyzed in parallel by
entrifugation in a sucrose density gradient (15–30%).
NA contained in each fraction was purified and di-
ested with DpnI to detect replicated plasmids by South-
rn hybridization. We found that the SV40 minichromo-
omes extracted from the nocodazole-treated cells were
ollected mostly in fraction 6 (Fig. 8A). Those extracted
rom the mimosine-treated cells were also recovered in
raction 6. Thus there were no differences in sedimenta-
ion velocity of the SV40 minichromosomes extracted
rom G2/M and late G1 cells. The same Southern mem-
ranes were also hybridized with the oriP probe to detect
he oriP minichromosome in each fraction. The oriP
inichromosomes extracted from the nocodazole-
transfected by the oriP plasmid and cultured in the presence of BRdU
k. The oriP plasmid was prepared according to Hirt’s method, and the
quilibrium centrifugation in CsCl. DNA in each fractions were detected
zation probe and quantified with Fuji image analyzer model BAS2000.
vy-light (HL), and light-light (LL) DNA are indicated above on the graph.
ted by model BAS2000.s were
le bloc
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48 SHIRAKATA, IMADOME, AND HIRAIame fraction in which the SV40 minichromosomes were
etected. In contrast, the oriP minichromosomes ex-
racted from the mimosine-treated cells (late G1) mi-
rated faster in a sucrose density gradient and were
ecovered mostly in fraction 4. The sedimentation veloc-
ty of the oriP minichromosome increased during a pe-
iod between G2/M and late G1. Difference in sedimen-
ation velocity was also confirmed in another experiment
sing a small amount of the minichromosome extracts
Fig. 8B). In this experiment, the oriP minichromosome of
ate G1 phase was collected in fraction 3 and the G2/M
inichromosome was collected in fraction 6. These re-
FIG. 4. Release from the G2/M block allowed the oriP plasmid to
eplicate in the subsequent S phases. (A) Protocol of the experiment.
he transfected cells were cultured in the presence of nocodazole for
4 h and then in normal medium. Cells were collected at 0, 24, 48, and
2 h after release from nocodazole block. (B) The DpnI–MboI assay.
he oriP plasmid (3 mg), the dam methylated control plasmid (3 mg),
nd the unmethylated control plasmid (3 mg) were cotransfected into
eLa/EB1 cells. Assay conditions and identification of the fragments
ere described in the legend to Fig. 1. (C) Summary of three experi-
ents.ults indicated that the oriP minichromosome existed in ewo distinct states during cell cycle: one formed in late
1 and the other formed in G2/M.
DISCUSSION
In this study, we have asked whether oriP requires
arly G1 phase for the next round of replication in S
hase. Using the transient replication assay with HeLa/
B1 cells, we demonstrated that the oriP plasmid did not
FIG. 5. The 24-h delay of the G2/M block allowed the oriP plasmids
ne round of replication after transfection. (A) Protocol of the experi-
ent. The transfected cells were cultured in normal medium for 24 h
nd then in the presence of nocodazole for an additional 24 h. Control
ells were cultured in normal medium. Cells were collected at the time
f addition of nocodazole (24 h) and 24 h later (48 h). (B) The DpnI–MboI
ssay. The oriP plasmid (3 mg), the dam methylated control plasmid (3
g), and the unmethylated control plasmid (3 mg) were cotransfected
nto HeLa/EB1 cells. Assay conditions and identification of the frag-
ents were described in the legend to Figure 1. (C) Summary of twoxperiments.
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49LICENSING OF EBV oriPeplicate in the initial S phase under G2/M block. The
lasmid replicated in the second S phase after release
rom the G2/M block. These results indicated that oriP
equires a cell cycle window that includes early G1 for
he next round of replication. We also found that the oriP
inichromosome existed in two distinct states, one
ormed in late G1 and the other formed in G2/M, sug-
esting that modification of the oriP minichromosome
ccurs during the cell cycle from G2/M to late G1. From
hese results, we suggest that the DS-dependent repli-
ation of the oriP minichromosome requires a replication
icensing, and this implies a possible involvement of the
ellular licensing factors in the replication from oriP.
In this study, we used the transient replication assay in
eLa/EB1 cells to examine the regulation of oriP. Repli-
ation of oriP was efficient in HeLa/EB1, and the repli-
ated plasmids were detected and quantified by South-
FIG. 6. The transfected DS plasmid did not replicate in the initial S p
pnI–MboI assay. The DS plasmid [DS, 3 mg], the dam methylated cont
2), 3 mg] were cotransfected into HeLa/EB1 cells. The transfected c
ransfection (Nocodazole). Another set of cells was cultured in normal m
combination of DpnI and XbaI or of MboI and XbaI. The hybridization p
.1-kb DpnI–MboI-resistant (resistant) and 1.1-kb -sensitive (digested) fr
f the dam methylated control plasmid [control (1)], and 6-kb resistant
ummary of two experiments.rn hybridization analysis. We estimated the average copy number of the replicated oriP plasmids as 600/cell
t 3 days after transfection and loss of the replicated
lasmids as 4%/generation in our transient replication
ssay (Fig. 7). This rate was close to those (5%) of the
everal oriP-containing plasmids in different cell lines
nder nonselective condition (Yates et al., 1984, 1985;
ugden et al., 1985; Middleton and Sugden, 1994), indi-
ating that there were no significant differences in the
etention of the oriP plasmid in HeLa/EB1 and these cell
ines. Our previous study (Shirakata and Hirai, 1998) has
hown that most replication occurred transiently in
eLa/EB1 (.99%) and depends on the DS element. Thus
he replication of the oriP plasmid in HeLa/EB1 repre-
ents that of the EBV genome using the DS element
unctions as a replication origin efficiently. In this re-
pect, our results obtained with HeLa/EB1 may not be
irectly compared with those of 143B, C33A, and 293
nder G2/M block. (A) Replication of the DS plasmid was analyzed by
mid [control (1), 3 mg], and the unmethylated control plasmid [control
ere cultured in the presence of nocodazole for 24, 48, or 72 h after
(Control). The plasmids recovered from these cells were digested with
as a 1-kb DpnI fragment of pBluescript II KS2 plasmid, which detected
s of the DS plasmid [oriP], 3-kb resistant and 1-kb digested fragments
-kb digested fragments of the unmethylated plasmid [control (2)]. (B)hase u
rol plas
ells w
edium
robe w
agment
and 2.9ells because several viral elements out of the DS ele-
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50 SHIRAKATA, IMADOME, AND HIRAIent can function as replication origins in these cells
Kirchmaier and Sugden, 1998; Aiyar et al., 1998).
The absence of the replicated oriP plasmid under
2/M block suggested that the plasmid did not repli-
ated in the initial S phase after transfection. This inter-
retation was based on that assumption that the plasmid
as transfected into G1 and S cells. We confirmed this
y transfecting the GFP expression plasmid and analyz-
ng the cell cycle distribution (Fig. 2). Because the stan-
ard fixation with ethanol for cell cycle analysis extracts
FP proteins from the cells, we fixed the transfected
ells sequentially with paraformaldehyde and ethanol.
his fixation method caused a lower resolution in the cell
ycle analysis. When we analyzed the ethanol-fixed cells,
e obtained the result indicating that 53% of cells were
n G0/G1, 35% were in S, and 12% were in G2/M, whereas
he cells fixed with paraformaldehyde and ethanol were
6% in G0/G1, 31% in S, and 23% in G2/M. Thus the
FIG. 7. Retention of the oriP plasmid and the DS plasmid in HeLa/EB1
ells. After transfection of the oriP plasmid or the DS plasmid, the
eLa/EB1 cells were grown by replating cells at 4, 8, 12, 16, and 20
ays under a nonselective condition. The same number of cells (2 3
06) were collected when cells were replating. The plasmids were
ecovered from these cells according to Hirt’s method, and the amount
f the plasmid was estimated by Southern hybridization and with Fuji
mage analyzer model BAS2000. (A) Southern hybridization. (B) Relative
opy number in the same number of cells. Signals were normalized to
hat of 4 days.ouble fixation resulted in a lower G0/G1 and a higher c2/M percentage, and the actual percentages of G1 and
cells in the GFP-expressing cells were higher than
hose shown in Fig. 2; the result suggested that plasmids
ere efficiently introduced into G1 and S cells according
o the calcium phosphate method. We also confirmed the
ransfection of plasmids into G1 and S cells by analyzing
eplication of the SV40 ori plasmid. The plasmid contain-
ng the SV40 origin replicated efficiently under G2/M
lock (results not shown), confirming that the transfec-
ion method actually introduced plasmids into G1 and S
ells. Based on these results, we concluded that the
bsence of replication under G2/M block indicated that
he passage through initial M phase and the entry into
arly G1 phase was required for the DNA replication of
he oriP plasmid in the next S phase. This was also
upported by two other experiments: the release from
he G2/M block (Fig. 4) and the 24-h delay of G2/M block
Fig. 5).
Because replication from oriP occurs only once in a
ingle S phase, it has been suggested that cellular ma-
hinery may regulate this viral replication (Yates and
uan, 1991). As we demonstrated, in the DS-dependent
eplication, oriP requires the passage through M phase
nd entry into G1 phase for the next replication. Because
eplication licensing of the cellular genome occurs dur-
ng the same cell cycle window, it is likely that oriP is
lso regulated by some licensing mechanism, but we do
ot yet understand the details of the licensing mecha-
ism of oriP. We also demonstrated in this study that the
S plasmid requires licensing for replication (Fig. 6). This
esult suggests that the licensing event may occur at the
eplication origin: the DS element. It is possible that one
f cell cycle-dependent protein kinases may modify
BNA1 to initiate DNA replication. The cellular licensing
actor MCM may also be involved in the licensing of oriP.
n this case, the initiation process of replication from oriP
ay be similar to those of cellular replication origins
ecause the MCM proteins are essential components of
he replication initiation machinery. It is important to
etermine whether MCM proteins are involved in the
S-dependent replication of the EBV genome.
We also demonstrated that the oriP minichromosome
xtracted from cells existed in two distinct states and
hat they can be separated by sucrose density gradient
entrifugation. The minichromosome extracted from late
1 cells sedimented faster than those of G2/M cells in a
ucrose density gradient (Fig. 8). The shift of two or three
ractions in a total of 11 fractions suggests a large in-
rease in molecular mass and/or structural change of
he minichromosome. Because no large changes in su-
ercoiling and nucleosome positioning of the minichro-
osome were observed between G2/M and late G1
results not shown), molecular mass of the minichromo-
ome should increase at late G1 phase. The association
f several replication factors [i.e., an MCM–hexamer
omplex (;600 kDa)] may occur at late G1, but it does
n
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51LICENSING OF EBV oriPot account for all of the difference in sedimentation
elocity. We therefore assume that in late G1 phase,
FIG. 8. Sucrose density gradient centrifugation analysis of the oriP min
nto HeLa/EB1 cells and cultured for 2 days before being treated with m
xtracted from these cells and analyzed by sucrose density gradient c
ybridization using the oriP specific or SV40 specific probes after Dpn
riP minichromosome and the SV40 ori minichromosome (bottom pane
locked (late G1) sample. Radioisotope signals of each fraction were q
mount of signals (top and middle panels). E, Nocodazole-blocked (G2/
f loaded plasmids was ;10-fold less than that of experiment 1.everal oriP minichromosomes may associate with aeplication factory and form a large complex in nuclei
reviewed by Cook, 1999).
osome. The oriP plasmid and the SV40 ori plasmid were cotransfected
e (late G1 block) or nocodazole (G2/M block). Minichromosomes were
ation. The DNA collected in each fraction was analyzed by Southern
baI digestion. The same Southern membrane was used to detect the
indicates nocodazole-blocked (G2/M) sample, and Mimo; mimosine-
d with model BAS2000 and were represented as the ratio to the total
imosine-blocked (late G1). (A) Experiment 1. (B) Experiment 2. Amountichrom
imosin
entrifug
I and X
l). Noc
uantifie
M). F, MoriP was initially identified by genetic analysis (Yates
e
c
(
S
E
D
t
r
o
r
o
p
i
p
t
D
w
p
l
v
p
E
i
c
c
f
1
f
c
T
k
K
t
T
(
t
g
a
u
K
T
k
a
d
y
H
t
H
r
t
m
(
e
r
w
m
d
S
f
t
t
f
1
f
n
t
s
D
c
a
T
p
T
A
s
o
g
1
1
a
w
s
a
f
s
p
a
p
d
t
a
q
s
d
t
u
e
p
C
m
a
s
52 SHIRAKATA, IMADOME, AND HIRAIt al., 1984), and the DS element functions as the repli-
ation origin when the DS-dependent replication occurs
Gahn and Schildkraut, 1989; Harrison et al., 1994;
hirakata and Hirai, 1998). However, replication of the
BV genome also occurs in a manner independent of the
S element in several EBV-infected cultured cells. When
he DS-independent replication occurs, initiation sites of
eplication are dispersed in a broad region distal from
riP, whereas replication from the DS element is very
are (Little and Schildkraut, 1995). This suggests that the
rigin function of the DS element is somehow sup-
ressed in these cell lines. Because transcription can
nterfere with DNA replication (Haase et al., 1994; Desh-
ande and Newlon, 1996), the transcriptional machinery
raveling in the oriP region may prevent licensing of the
S element in G1 phase. The EBV-positive cell lines, in
hich the DS-independent replication is observed, ex-
ress most of the nuclear antigens (EBNA1–6) and the
atent membrane proteins (LMP1, LMP2). Some of these
irus-encoded proteins may be responsible for the sup-
ression of DS-dependent replication. Alternatively,
BNA1 may be modified in these cells so as not to
nitiate replication from oriP. In contrast to these cultured
ell lines, the EBV-positive Burkitt’s lymphoma and the
irculating EBV-infected B cells express only EBNA1 and
ew EBV proteins (reviewed in Thorley-Lawson et al.,
996). The licensing regulation of oriP may be important
or the maintenance of EBV genome in the EBNA1-only
ells.
MATERIALS AND METHODS
ransient replication assay
The oriP plasmid (5.2 kb) contained the oriP region (2.2
b) of EBV B95-8 at the multicloning site of pBluescript II
S2 vector (Stratagene). The DS plasmid (3.1 kb) con-
ained only the DS element at the same site of the vector.
hese plasmids were described in a previous report
Shirakata and Hirai, 1998). For the dam methylated con-
rol plasmid (12 kb), a 9-kb EcoRI fragment of human Ig
ene was subcloned in the pBluescript II KS2 plasmid
nd maintained in Escherichia coli HB101 (dam1). For the
nmethylated control plasmid (3 kb), the pBluescript II
S2 plasmid was maintained in E. coli SCS110 (dam2).
he deletion mutant of pBluescript II KS2 plasmid (2.2
b) was used as the unmethylated control plasmid in the
nalysis of the DS plasmid. The oriP plasmid (3 mg), the
am methylated control plasmid (3 mg), and the unmeth-
lated control plasmid (3 mg) were cotransfected into the
eLa/EB1 cells (2.5 3 106) in a 100-mm dish according to
he calcium phosphate method. HeLa/EB1 cells were
eLa cells stably expressing EBNA1 (Shirakata and Hi-
ai, 1998). After glycerol shock, cells were maintained in
he same dishes for 24, 48, 72, or 96 h with normal
edium or the medium containing 100 ng/ml nocodazole
Sigma) according to the protocols described in the leg- wnds to the figures. Cells were scraped off with silicon
ubber and collected by centrifugation. The plasmids
ere recovered from these cells according to Hirt’s
ethod. Cells collected from a single 100-mm dish were
issolved in extraction buffer (400 ml) containing 0.6%
DS, 10 mM EDTA, and 20 mM Tris–HCl, pH 8; trans-
erred to a 1.5-ml tube; and incubated for 10 min at room
emperature to dissolve the cells. NaCl (5 M; 100 ml) was
hen added, and the mixture was further incubated on ice
or 30 min. The sample was centrifuged at 14,000 rpm for
h using a microfuge, and the supernatant was trans-
erred into a new tube. The plasmid DNA in the super-
atant was purified with phenol and chloroform extrac-
ion and ethanol precipitation. Final precipitates were dis-
olved in 50 ml TE (10 mM Tris–HCl, pH 8.0, 1 mM EDTA).
pnI–MboI assay
To linearize plasmids, 5 ml of samples (10% of total
ells in a dish) was first digested with XbaI (10 U) for 1 h
t 37°C in digestion buffer (25 ml) containing 20 mM
ris-acetate, pH 7.9, 10 mM magnesium acetate, 50 mM
otassium acetate, 1 mM dithiothreitol, 0.1% BSA, 0.01%
riton X-100, 3 mM spermidine, and 20 mg/ml RNase.
fter XbaI digestion, 1 M NaCl (6 ml) was added, and the
amples were further digested with DpnI (10 U) for an-
ther hour at 37°C. For MboI digestion, the XbaI-di-
ested samples were further digested with MboI (5 U) for
h at 37°C. Under this digestive condition (DePamphilis,
995), DpnI cuts the GATC sites only when both strands
re methylated, and MboI digests the same sites only
hen both strands are unmethylated. These digested
amples were electrophoresed in a 0.7% agarose gel
nd transferred to a Hybond N1 membrane (Amersham)
or hybridization. The 1-kb DpnI fragment of the pBlue-
cript II KS2 plasmid was used for the hybridization
robe. A small amount of alkali-denatured plasmids, an
rtifact of plasmid preparation, was contained in the
lasmids used for the transfection. Restriction enzymes
id not digest the denatured plasmid, which was de-
ected at the position indicated by a star in Southern
nalysis. Radioisotope on the Southern membranes was
uantified with Fuji image analyzer model BAS2000. The
ignals of the DpnI-resistant oriP plasmids and MboI-
igested oriP plasmids were normalized to those of con-
rol plasmids. Quantification of plasmids was done by
sing a signal of the oriP plasmid of known amount (2 ng)
lectrophoresed in parallel in the agarose gel, and the
lasmid amount in a single dish was calculated.
ell cycle analysis of the plasmid-transfected cells
The GFP-expressing plasmid pEGFP-C2 (Clontech) (10
g) was transfected into HeLa/EB1 cells (2.5 3 106)
ccording to the calcium phosphate method as de-
cribed for the transient replication assay. These cells
ere treated with 10% glycerol in PBS for 2 min at 4 h
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53LICENSING OF EBV oriPfter transfection. At 2 or 24 h after glycerol treatment,
ells were trypsinized and collected. After washing with
BS, cells were suspended in 1 ml of PBS and fixed by
he addition of 1 ml of 4% paraformaldehyde in PBS that
as preheated at 37°C. This initial fixation was per-
ormed at room temperature for 5 min and stopped by the
ddition of 2 ml of 50 mM NH4Cl in PBS. Cells were
ollected by a centrifugation and fixed further with 3 ml of
0% ethanol at 4°C for overnight. These cells were col-
ected and stained with 1 ml of propidium iodide staining
olution (50 mg/ml propidium iodide, 100 U/ml RNase A,
.1% glucose in PBS). Expression of GFP and DNA con-
ent of cells were analyzed with FACS Calibur (Becton-
ickinson). Cell cycle analysis was performed using a
odFit LT V2.0 program.
RdU labeling assay
The oriP plasmid (5 mg) was transfected into HeLa/
B1 cells as described for the transient replication as-
ay. After transfection, cells were cultured in the pres-
nce of 0.3 mM BRdU, 0.1 mM deoxycytidine, and 100
g/ml nocodazole for 24 h. Control cells were cultured
ithout nocodazole. The plasmid was recovered from
hese cells according to Hirt’s method. Genomic DNA
as also prepared from these cells by SDS–proteinase K
xtraction and phenol–chloroform purification. The CsCl
olution containing the DNA sample was prepared at
ensity of 1.74 g/ml and centrifuged at 70,000 rpm for 24 h
t 20°C using a Beckman TLV100 rotor. Samples were
ollected from the bottom of tubes (21 fractions), and
NA contained in each fractions (100 ml) was precipi-
ated with ethanol and sodium acetate. The samples
ere dissolved with 50 ml of TE, and then 3 ml of 5 M
aOH was added and incubated at 65°C for 30 min. After
ooling down to room temperature, the sample was
ixed with 16 ml of 203 SSC and applied to a membrane
sing a slot-blot manifold. The plasmid and genomic
NAs were detected by Southern hybridization using
riP and Alu sequences as probes, respectively. Hybrid-
zation signal was quantified with Fuji image analyzer
odel BAS2000.
ucrose density gradient centrifugation
The SV40 ori plasmid was constructed by joining the T
ntigen expression plasmid and pSV2hph. The oriP plas-
id (5 mg) and the SV40 ori plasmid (5 mg) were cotrans-
ected into HeLa/EB1 cells in a 100-mm dish as de-
cribed in the transient replication assay. Cells were
ultured in normal medium for 2 days and then in the
edium containing mimosine or nocodazole for 24 h.
ells were collected from three 100-mm dishes and
ashed once with PBS. The oriP minichromosome and
he SV40 minichromosome were extracted from cells
ith 1 ml of the Triton extraction buffer (10 mM KCl, 10
M HEPES-NaOH, pH7.4, 1.5 mM MgCl2, 1 mM dithio-hreitol, 1 mM ATP, 1% Triton X-100) with slow rotations at
°C for 60 min. The extracts were centrifuged for 3 min
t 3000 rpm by a microfuge to obtain the low-speed
upernatant (1 ml). The supernatant was loaded onto the
op of 15–30% sucrose gradient (11 ml) in a centrifuge
ube. The sucrose solution was buffered with 10 mM
EPES-NaOH, pH 7.4, and the gradient was preincu-
ated for 1 h at 4°C before loading the sample. The
entrifugation was performed with a SW40Ti rotor (Beck-
an) at 38,000 rpm for 3 h at 4°C. Fractions were col-
ected from the bottom of tubes. DNA contained in each
raction was purified by protenase K digestion and phe-
ol–chloroform extraction. Half of the DNA prepared from
ach fraction was digested with XbaI and DpnI as de-
cribed in the DpnI–MboI assay and analyzed by South-
rn hybridization. The same Southern membranes were
sed to detect the oriP plasmid and the SV40 ori plasmid.
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